Leading the Future in Point of Care Diagnostics

GET CONNECTED
innsightech.com

InnSight Technology

Company details

InnSight Technology is a leader in ophthalmic diagnostics and tear fluid testing. Our product, OcuCheck, disrupts industry predicates with superior technology to provide more accurate, versatile and reliable testing of molecular biomarker in tear fluid that will improve patient care in dry eye disease and open new opportunities for health monitoring through noninvasive, tear fluid testing.

United StatesHAX Seed 2024

Get In Touch with InnSight Technology

Please tell us a little bit about yourself and why you'd like to get connected. InnSight Technology + SOSV will follow up with you via email.

Hidden
Hidden
Hidden
Hidden
Opt-in checkbox


We don’t spam. Our Privacy Policy and Terms of Use apply.
* If you are interested in investing directly into SOSV's portfolio of privately held companies, or into SOSV's funds, you need to meet the SEC’s criteria for accredited investor status. As an individual, you can qualify as an accredited investor by either (a) having more than $200,000 in annual income for each of the past two years (or $300,000 with your spouse) and a reasonable expectation of earning the same this year or (b) having a net worth of at least $1 million (not including your principal residence). Learn More